Protocol No.: M16-049

Title
An Open-label Multiple Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects with Severe Atopic Dermatitis
Principal Investigator
Zinn, Zachary
Phase
I
Age Group
Children
Applicable Disease Site
Other
Participating Institution
Health Sciences Center
Contacts
Tracy Yang, RN
Research Specialist
Phone: +1 304-293-4879
Erica Blystone, RN
Clinical Research Specialist
Phone: +1 304-293-3415

View on ClinicalTrials.gov